These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 28404651)

  • 1. Resistance profile of drugs composing the "shorter" regimen for multidrug-resistant tuberculosis in Brazil, 2000-2015.
    Dalcolmo M; Gayoso R; Sotgiu G; D'Ambrosio L; Rocha JL; Borga L; Fandinho F; Braga JU; Arakaki Sanchez D; Dockhorn F; Centis R; Migliori GB
    Eur Respir J; 2017 Apr; 49(4):. PubMed ID: 28404651
    [No Abstract]   [Full Text] [Related]  

  • 2. Is Shorter Treatment Regimen for Multidrug-resistant Tuberculosis feasible in Indian Children?
    Shah I
    Indian Pediatr; 2017 Feb; 54(2):160. PubMed ID: 28285296
    [No Abstract]   [Full Text] [Related]  

  • 3. Anti-tuberculosis drug resistance in new and previously treated pulmonary tuberculosis cases in Burkina Faso.
    Sangaré L; Diandé S; Badoum G; Dingtoumda B; Traoré AS
    Int J Tuberc Lung Dis; 2010 Nov; 14(11):1424-9. PubMed ID: 20937182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Practical considerations to implement the shorter regimen to MDR-TB patients in China.
    Liu Q; Sun F; Li Y; Bao J; Zhang Y; Zhang W
    Clin Microbiol Infect; 2018 Oct; 24(10):1035-1036. PubMed ID: 29730223
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug-resistant Mycobacterium tuberculosis, Taiwan.
    Jou R; Chuang PC; Wu YS; Yan JJ; Luh KT
    Emerg Infect Dis; 2006 May; 12(5):871-2. PubMed ID: 16710962
    [No Abstract]   [Full Text] [Related]  

  • 6. Dynamics of multidrug resistant tuberculosis in Veracruz, México between 2002 and 2008.
    Zenteno-Cuevas R; Rubi A; Fuentes-Dominguez J; Lara-Gonzalez JL; Escobar-Mesa A
    J Infect Dev Ctries; 2010 Nov; 4(11):776-8. PubMed ID: 21252458
    [No Abstract]   [Full Text] [Related]  

  • 7. [Shortened, strictly supervised tuberculosis treatment in populations with moderate drug resistance levels: international impact perspective].
    Santos-Preciado JI; Franco-Paredes C
    Rev Invest Clin; 2005; 57(3):488-90. PubMed ID: 16187710
    [No Abstract]   [Full Text] [Related]  

  • 8. High prevalence of multidrug-resistant tuberculosis in Zunyi, Guizhou Province of China.
    Chen L; Li N; Liu M; Zhang J; Zhang H
    J Antimicrob Chemother; 2011 Oct; 66(10):2435-7. PubMed ID: 21795258
    [No Abstract]   [Full Text] [Related]  

  • 9. [Mycobacterium tuberculosis drug resistance in HIV patients in Baixada Santista, São Paulo, Brazil].
    Rozman LM; Santo AH; Rozman MA
    Cad Saude Publica; 2007 May; 23(5):1051-9. PubMed ID: 17486228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acquired Drug Resistance in Mycobacterium tuberculosis and Poor Outcomes among Patients with Multidrug-Resistant Tuberculosis.
    Kempker RR; Kipiani M; Mirtskhulava V; Tukvadze N; Magee MJ; Blumberg HM
    Emerg Infect Dis; 2015 Jun; 21(6):992-1001. PubMed ID: 25993036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High rate of acquired resistance to tuberculosis among HIV-infected subjects of Chennai, South India.
    Vignesh R; Balakrishnan P; Shankar EM; Murugavel KG; Hanas S; Cecelia AJ; Thyagarajan SP; Solomon S; Kumarasamy N; Mayer KH
    J Infect; 2007 Dec; 55(6):e141-2. PubMed ID: 18029020
    [No Abstract]   [Full Text] [Related]  

  • 12. Concomitant increases in spectrum and level of drug resistance in Mycobacterium tuberculosis isolates.
    Sun Z; Zhang J; Song H; Zhang X; Li Y; Tian M; Liu Y; Zhao Y; Li C
    Int J Tuberc Lung Dis; 2010 Nov; 14(11):1436-41, i. PubMed ID: 20937184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug resistance of M. tuberculosis isolated from patients with HIV infection seen at an AIDS Reference Center in São Paulo, Brazil.
    Pinto WP; Hadad DJ; Palhares MC; Ferrazoli L; Telles MA; Ueki SY; Santos MT; Placco AL; Sauaia N; Palaci M
    Rev Inst Med Trop Sao Paulo; 1996; 38(1):15-21. PubMed ID: 8762634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The "source" of drug-resistant TB outbreaks.
    van Helden PD; Victor T; Warren RM
    Science; 2006 Oct; 314(5798):419-20. PubMed ID: 17053131
    [No Abstract]   [Full Text] [Related]  

  • 15. [Association of tuberculosis and HIV infection in Brazil].
    Kritski A; Dalcolmo M; del Bianco R; del Melo FF; Pinto WP; Schechther M; Castelo A
    Bol Oficina Sanit Panam; 1995 Jun; 118(6):542-54. PubMed ID: 7626227
    [No Abstract]   [Full Text] [Related]  

  • 16. DOTS and drug resistance: a silver lining to a darkening cloud.
    Chaisson RE; Coberly JS; De Cock KM
    Int J Tuberc Lung Dis; 1999 Jan; 3(1):1-3. PubMed ID: 10094162
    [No Abstract]   [Full Text] [Related]  

  • 17. Mycobacterium tuberculosis resistance in HIV-infected patients from a tertiary care teaching hospital in Porto Alegre, southern Brazil.
    Wolfart M; Barth AL; Willers D; Zavascki AP
    Trans R Soc Trop Med Hyg; 2008 May; 102(5):421-5. PubMed ID: 18394664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of drug-resistant Mycobacterium tuberculosis in patients under intermittent or daily treatment.
    Alvarez TA; Rodrigues MP; Viegas CA
    J Bras Pneumol; 2009 Jun; 35(6):555-60. PubMed ID: 19618036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of primary drug resistance in pulmonary tuberculosis patients with no known risk factors for such.
    Bastos GM; Cezar MC; Mello FC; Conde MB
    J Bras Pneumol; 2012; 38(6):733-9. PubMed ID: 23288118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary drug resistance among pulmonary treatment-naïve tuberculosis patients in Amazonas State, Brazil.
    da Silva Garrido M; Ramasawmy R; Perez-Porcuna TM; Zaranza E; Chrusciak Talhari A; Martinez-Espinosa FE; Bührer-Sékula S
    Int J Tuberc Lung Dis; 2014 May; 18(5):559-63. PubMed ID: 24903793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.